CPRX logo

Catalyst Pharmaceuticals, Inc. (CPRX) Depreciation and amortization

annual D&A:

$38.05M+$4.91M(+14.81%)
December 31, 2024

Summary

  • As of today (September 10, 2025), CPRX annual depreciation & amortization is $38.05 million, with the most recent change of +$4.91 million (+14.81%) on December 31, 2024.
  • During the last 3 years, CPRX annual D&A has risen by +$37.57 million (+7761.98%).
  • CPRX annual D&A is now at all-time high.

Performance

CPRX Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

quarterly D&A:

$9.53M+$2000.00(+0.02%)
June 30, 2025

Summary

  • As of today (September 10, 2025), CPRX quarterly depreciation & amortization is $9.53 million, with the most recent change of +$2000.00 (+0.02%) on June 30, 2025.
  • Over the past year, CPRX quarterly D&A has increased by +$30.00 thousand (+0.32%).
  • CPRX quarterly D&A is now at all-time high.

Performance

CPRX quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

TTM D&A:

$38.12M+$30.00K(+0.08%)
June 30, 2025

Summary

  • As of today (September 10, 2025), CPRX TTM depreciation & amortization is $38.12 million, with the most recent change of +$30.00 thousand (+0.08%) on June 30, 2025.
  • Over the past year, CPRX TTM D&A has increased by +$1.27 million (+3.45%).
  • CPRX TTM D&A is now at all-time high.

Performance

CPRX TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXincome statement metrics

CPRX Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.8%+0.3%+3.5%
3 y3 years+7762.0%+9530.3%+8543.1%
5 y5 years+10000.0%+1285.8%+3558.0%

CPRX Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7762.0%at high+9530.3%at high+8543.1%
5 y5-yearat high>+9999.0%at high>+9999.0%at high>+9999.0%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

CPRX Depreciation and amortization History

DateAnnualQuarterlyTTM
Jun 2025
-
$9.53M(+0.0%)
$38.12M(+0.1%)
Mar 2025
-
$9.53M(+0.0%)
$38.09M(+0.1%)
Dec 2024
$38.05M(+14.8%)
$9.53M(+0.1%)
$38.05M(+0.8%)
Sep 2024
-
$9.52M(+0.2%)
$37.73M(+2.4%)
Jun 2024
-
$9.50M(+0.1%)
$36.85M(+2.4%)
Mar 2024
-
$9.50M(+3.1%)
$35.98M(+8.6%)
Dec 2023
$33.14M(+2130.3%)
$9.21M(+6.7%)
$33.14M(+34.7%)
Sep 2023
-
$8.63M(-0.0%)
$24.61M(+48.3%)
Jun 2023
-
$8.63M(+29.6%)
$16.59M(+106.0%)
Mar 2023
-
$6.66M(+882.9%)
$8.06M(+442.1%)
Dec 2022
$1.49M(+207.0%)
$678.00K(+10.2%)
$1.49M(+62.1%)
Sep 2022
-
$615.00K(+521.2%)
$917.00K(+107.9%)
Jun 2022
-
$99.00K(+5.3%)
$441.00K(-8.3%)
Mar 2022
-
$94.00K(-13.8%)
$481.00K(-0.6%)
Dec 2021
$484.00K(-45.3%)
$109.00K(-21.6%)
$484.00K(+19.1%)
Sep 2021
-
$139.00K(0.0%)
$406.50K(+13.9%)
Jun 2021
-
$139.00K(+43.3%)
$356.80K(-60.6%)
Mar 2021
-
$97.00K(+207.9%)
$905.80K(+2.3%)
Dec 2020
$885.30K(+197.4%)
$31.50K(-64.7%)
$885.30K(-21.3%)
Sep 2020
-
$89.30K(-87.0%)
$1.12M(+7.9%)
Jun 2020
-
$688.00K(+799.3%)
$1.04M(+189.1%)
Mar 2020
-
$76.50K(-71.8%)
$360.40K(+21.1%)
Dec 2019
$297.70K(+683.4%)
$271.00K(+4069.2%)
$297.60K(+661.1%)
Sep 2019
-
$6500.00(+1.6%)
$39.10K(-6.7%)
Jun 2019
-
$6400.00(-53.3%)
$41.90K(-4.1%)
Mar 2019
-
$13.70K(+9.6%)
$43.70K(+15.0%)
Dec 2018
$38.00K(-16.8%)
$12.50K(+34.4%)
$38.00K(+17.3%)
Sep 2018
-
$9300.00(+13.4%)
$32.40K(-9.7%)
Jun 2018
-
$8200.00(+2.5%)
$35.90K(-11.8%)
Mar 2018
-
$8000.00(+15.9%)
$40.70K(-10.9%)
Dec 2017
$45.70K(+5.3%)
$6900.00(-46.1%)
$45.70K(-10.0%)
Sep 2017
-
$12.80K(-1.5%)
$50.80K(+6.9%)
Jun 2017
-
$13.00K(0.0%)
$47.50K(+9.7%)
Mar 2017
-
$13.00K(+8.3%)
$43.30K(-0.5%)
Dec 2016
$43.40K(+25.8%)
$12.00K(+26.3%)
$43.50K(+15.7%)
Sep 2016
-
$9500.00(+8.0%)
$37.60K(-4.6%)
Jun 2016
-
$8800.00(-33.3%)
$39.40K(-0.5%)
Mar 2016
-
$13.20K(+116.4%)
$39.60K(+14.8%)
Dec 2015
$34.50K
$6100.00(-46.0%)
$34.50K(-5.2%)
DateAnnualQuarterlyTTM
Sep 2015
-
$11.30K(+25.6%)
$36.40K(+12.7%)
Jun 2015
-
$9000.00(+11.1%)
$32.30K(+9.9%)
Mar 2015
-
$8100.00(+1.3%)
$29.40K(+10.5%)
Dec 2014
$26.60K(+18.2%)
$8000.00(+11.1%)
$26.60K(+9.5%)
Sep 2014
-
$7200.00(+18.0%)
$24.30K(+6.6%)
Jun 2014
-
$6100.00(+15.1%)
$22.80K(+1.8%)
Mar 2014
-
$5300.00(-7.0%)
$22.40K(-0.4%)
Dec 2013
$22.50K(+106.4%)
$5700.00(0.0%)
$22.50K(+15.4%)
Sep 2013
-
$5700.00(0.0%)
$19.50K(+18.2%)
Jun 2013
-
$5700.00(+5.6%)
$16.50K(+22.2%)
Mar 2013
-
$5400.00(+100.0%)
$13.50K(+23.9%)
Dec 2012
$10.90K(-74.5%)
$2700.00(0.0%)
$10.90K(-32.3%)
Sep 2012
-
$2700.00(0.0%)
$16.10K(-23.0%)
Jun 2012
-
$2700.00(-3.6%)
$20.90K(-46.7%)
Mar 2012
-
$2800.00(-64.6%)
$39.20K(-8.4%)
Dec 2011
$42.80K(+66.5%)
$7900.00(+5.3%)
$42.80K(+3.6%)
Sep 2011
-
$7500.00(-64.3%)
$41.30K(+3.3%)
Jun 2011
-
$21.00K(+228.1%)
$40.00K(+58.1%)
Mar 2011
-
$6400.00(0.0%)
$25.30K(-1.6%)
Dec 2010
$25.70K(-14.9%)
$6400.00(+3.2%)
$25.70K(-2.7%)
Sep 2010
-
$6200.00(-1.6%)
$26.40K(-4.0%)
Jun 2010
-
$6300.00(-7.4%)
$27.50K(-5.2%)
Mar 2010
-
$6800.00(-4.2%)
$29.00K(-4.0%)
Dec 2009
$30.20K(-7.9%)
$7100.00(-2.7%)
$30.20K(-3.5%)
Sep 2009
-
$7300.00(-6.4%)
$31.30K(-2.8%)
Jun 2009
-
$7800.00(-2.5%)
$32.20K(-1.2%)
Mar 2009
-
$8000.00(-2.4%)
$32.60K(-0.6%)
Dec 2008
$32.80K(+107.6%)
$8200.00(0.0%)
$32.80K(+1.5%)
Sep 2008
-
$8200.00(0.0%)
$32.30K(+17.5%)
Jun 2008
-
$8200.00(0.0%)
$27.50K(+25.6%)
Mar 2008
-
$8200.00(+6.5%)
$21.90K(+38.6%)
Dec 2007
$15.80K(+222.4%)
$7700.00(+126.5%)
$15.80K(+79.5%)
Sep 2007
-
$3400.00(+30.8%)
$8800.00(+17.3%)
Jun 2007
-
$2600.00(+23.8%)
$7500.00(+53.1%)
Mar 2007
-
$2100.00(+200.0%)
$4900.00(+75.0%)
Dec 2006
$4900.00(+250.0%)
$700.00(-66.7%)
$2800.00(+33.3%)
Sep 2006
-
$2100.00
$2100.00
Dec 2005
$1400.00(+250.0%)
-
-
Dec 2004
$400.00
-
-

FAQ

  • What is Catalyst Pharmaceuticals, Inc. annual depreciation & amortization?
  • What is the all time high annual D&A for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. annual D&A year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. quarterly D&A year-on-year change?
  • What is Catalyst Pharmaceuticals, Inc. TTM depreciation & amortization?
  • What is the all time high TTM D&A for Catalyst Pharmaceuticals, Inc.?
  • What is Catalyst Pharmaceuticals, Inc. TTM D&A year-on-year change?

What is Catalyst Pharmaceuticals, Inc. annual depreciation & amortization?

The current annual D&A of CPRX is $38.05M

What is the all time high annual D&A for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high annual depreciation & amortization is $38.05M

What is Catalyst Pharmaceuticals, Inc. annual D&A year-on-year change?

Over the past year, CPRX annual depreciation & amortization has changed by +$4.91M (+14.81%)

What is Catalyst Pharmaceuticals, Inc. quarterly depreciation & amortization?

The current quarterly D&A of CPRX is $9.53M

What is the all time high quarterly D&A for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high quarterly depreciation & amortization is $9.53M

What is Catalyst Pharmaceuticals, Inc. quarterly D&A year-on-year change?

Over the past year, CPRX quarterly depreciation & amortization has changed by +$30.00K (+0.32%)

What is Catalyst Pharmaceuticals, Inc. TTM depreciation & amortization?

The current TTM D&A of CPRX is $38.12M

What is the all time high TTM D&A for Catalyst Pharmaceuticals, Inc.?

Catalyst Pharmaceuticals, Inc. all-time high TTM depreciation & amortization is $38.12M

What is Catalyst Pharmaceuticals, Inc. TTM D&A year-on-year change?

Over the past year, CPRX TTM depreciation & amortization has changed by +$1.27M (+3.45%)
On this page